TrialThe New England journal of medicine2018

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Joseph M Connors et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.